Bitcoin (BTC) extended its decline, plunging another 5% to sub-$65,000 levels amid renewed concerns over President Trump’s tariffs, and AI investment dented investorBitcoin (BTC) extended its decline, plunging another 5% to sub-$65,000 levels amid renewed concerns over President Trump’s tariffs, and AI investment dented investor

Bitcoin Price Analysis: BTC Is Heading For Its Worst Month Since 2022, More Pain Ahead?

2026/02/25 19:02
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Bitcoin (BTC) extended its decline, plunging another 5% to sub-$65,000 levels amid renewed concerns over President Trump’s tariffs, and AI investment dented investor sentiment. Analysts are closely watching the $60,000 support level, with a drop towards $55,000 on the cards if the level is breached.

Concerns around Trump’s tariff strategy have become front and center in recent weeks. The president’s threats to impose financial sanctions on China, the EU, and other allies have triggered regular mass liquidations, dampening investor sentiment.

Bitcoin Quantum Threat Years Away: Michael Saylor

Strategy executive chairman Michael Saylor has downplayed concerns about quantum computing and its impact on Bitcoin. Saylor highlighted the consensus among the cybersecurity community that any credible quantum threat to the flagship cryptocurrency is likely a decade away. Saylor added that any quantum breakthrough would trigger immediate and coordinated software upgrades across global banking systems, internet infrastructure, consumer devices, artificial intelligence networks, and crypto protocols, including Bitcoin.

“You’ll see it coming. We’ll all see it coming.”

Saylor added that Bitcoin’s software is designed to change over time as its nodes, hardware, and wallets can initiate upgrades in response to emerging threats. The Strategy chairman believes global consensus on how to respond to such threats would emerge only if a credible threat is discovered, adding that governments, financial institutions, and tech companies face the same risk to their systems.

“I think the crypto community will be the first to perceive the threat, and to react to the threat, and they’ll be leading the way.”

World Liberty Financial Being Targeted By Hackers

Trump-family-backed World Liberty Financial is reportedly being targeted by hackers, short sellers, and paid influencers in an effort to “manufacture chaos” against the USD1 stablecoin. The company disclosed the attack in a post on X, stating that hackers targeted several WLFI co-founder accounts and opened massive short positions against the company. The hackers also paid influencers to spread fear, uncertainty, and doubt (FUD) against the company.

“A coordinated attack was launched against USD1 this morning. Attackers hacked several WLFI cofounder accounts, paid influencers to spread FUD, and opened massive WLFI shorts to profit from the manufactured chaos.”

Bitcoin (BTC) Price Analysis

Bitcoin (BTC) extended its recent downturn after falling to $65,000 on Monday as concerns around tariffs and AI investments dented investor confidence. The flagship cryptocurrency dropped another 5% to a low of $62,709, moving to $63,174 after reclaiming $63,000. The price is down 7% every week, trading around levels last seen on February 6.

Analysts are keeping an eye on the $60,000 support level, noting that if it fails to hold, BTC could slide towards $50,000. Matt Howells-Barby, vice president at Kraken, stated,

“Similar to equities, Bitcoin has had a sharp pullback today, driven largely by renewed tariff-related uncertainty, similar to the events of April 2025. Furthermore, ratcheting geopolitical tensions could likely prove bearish for BTC in the short term. The $60,000 level is a key support that bulls are watching closely. If that level fails to hold, we could potentially see a move into the mid-to-low $50K range.”

US stock markets also plummeted after President Trump announced he would impose a temporary 15% tariff on imports from other countries, up from the 10% announced on Friday after the US Supreme Court struck down the President’s tariff strategy.

Meanwhile, historical data reveals Bitcoin could be in for further downside. According to market experts, BTC rarely hits a bottom until the 50-week average price crosses below the 100-week average price. This bear cross has signalled the end of several bear markets, including the 2018 and 2022 bear markets. Currently, the 50-week average price is well above the 100-week average price. If we go by this metric, BTC could slide to $50,000 before bottoming.

BTC experienced substantial volatility at the beginning of the previous week, ultimately registering a marginal increase. Selling pressure returned on Tuesday as the price fell by over 2% to $67,466. Sellers retained control on Wednesday as BTC fell 1.55% to $66,419. Despite the overwhelming selling pressure, the price recovered on Thursday, rising almost 1% to $66,972. BTC continued pushing higher on Friday, rising 1.51% to $67,984.

Source: TradingView

Price action was muted over the weekend as BTC registered a marginal decline on Saturday and fell 0.50% on Sunday to $67,955. Selling pressure intensified on Monday as the price plunged over 4% to $64,625. Bearish sentiment has persisted during the ongoing session, with BTC down over 2% at $63,197.

Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.


Bitcoin Price Analysis: BTC Is Heading For Its Worst Month Since 2022, More Pain Ahead? was originally published in Coinmonks on Medium, where people are continuing the conversation by highlighting and responding to this story.

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$68,029.99
$68,029.99$68,029.99
-0.69%
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09